Farther Finance Advisors LLC Sells 216 Shares of Chemed Co. (NYSE:CHE)

Farther Finance Advisors LLC decreased its stake in shares of Chemed Co. (NYSE:CHE) by 63.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 122 shares of the company’s stock after selling 216 shares during the period. Farther Finance Advisors LLC’s holdings in Chemed were worth $65,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of CHE. EverSource Wealth Advisors LLC raised its holdings in Chemed by 7.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock valued at $264,000 after acquiring an additional 33 shares in the last quarter. Tortoise Investment Management LLC raised its stake in Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares in the last quarter. Independent Advisor Alliance lifted its position in Chemed by 1.1% during the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after purchasing an additional 25 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Chemed by 36.7% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,406 shares of the company’s stock worth $1,804,000 after buying an additional 914 shares in the last quarter. Finally, Personal CFO Solutions LLC increased its holdings in Chemed by 11.2% in the 4th quarter. Personal CFO Solutions LLC now owns 618 shares of the company’s stock valued at $328,000 after buying an additional 62 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on CHE shares. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada raised their price objective on Chemed from $633.00 to $667.00 and gave the company an “outperform” rating in a research note on Friday, March 14th.

Chemed Stock Down 1.2 %

CHE opened at $594.41 on Friday. The stock has a market cap of $8.70 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $648.29. The company has a fifty day moving average of $567.72 and a 200-day moving average of $565.52.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.05%.

Insider Buying and Selling at Chemed

In other news, VP Brian C. Judkins acquired 145 shares of the business’s stock in a transaction on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the acquisition, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. The trade was a 1.91 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.